NO20010569L - Proteaseinhibitorer for anvendelse ved behandling av psoriasis - Google Patents
Proteaseinhibitorer for anvendelse ved behandling av psoriasisInfo
- Publication number
- NO20010569L NO20010569L NO20010569A NO20010569A NO20010569L NO 20010569 L NO20010569 L NO 20010569L NO 20010569 A NO20010569 A NO 20010569A NO 20010569 A NO20010569 A NO 20010569A NO 20010569 L NO20010569 L NO 20010569L
- Authority
- NO
- Norway
- Prior art keywords
- protease inhibitors
- psoriasis
- treatment
- inhibitors
- pai
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title abstract 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title abstract 3
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- 102000035195 Peptidases Human genes 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 102000004179 Plasminogen Activator Inhibitor 2 Human genes 0.000 abstract 2
- 108090000614 Plasminogen Activator Inhibitor 2 Proteins 0.000 abstract 2
- 102100039419 Plasminogen activator inhibitor 2 Human genes 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 101710097834 Thiol protease Proteins 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 239000003001 serine protease inhibitor Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 108010065822 urokinase inhibitor Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP5087A AUPP508798A0 (en) | 1998-08-05 | 1998-08-05 | Method of treating psoriasis |
| PCT/IB1999/001483 WO2000007620A1 (en) | 1998-08-05 | 1999-08-05 | Protease inhibitors for use in the treatment of psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010569D0 NO20010569D0 (no) | 2001-02-02 |
| NO20010569L true NO20010569L (no) | 2001-04-04 |
Family
ID=3809320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010569A NO20010569L (no) | 1998-08-05 | 2001-02-02 | Proteaseinhibitorer for anvendelse ved behandling av psoriasis |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6288025B1 (de) |
| EP (1) | EP1102599A4 (de) |
| JP (1) | JP2002522396A (de) |
| KR (1) | KR20010072278A (de) |
| CN (1) | CN1322138A (de) |
| AU (1) | AUPP508798A0 (de) |
| CA (1) | CA2339485A1 (de) |
| IL (1) | IL141056A0 (de) |
| NO (1) | NO20010569L (de) |
| WO (1) | WO2000007620A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ380699A0 (en) * | 1999-11-02 | 1999-11-25 | Biotech Australia Pty Limited | Protease inhibitors as modulators of periodontal wound healing |
| ATE439853T1 (de) * | 2002-11-20 | 2009-09-15 | Arriva Prometic Inc | Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin |
| SE531785C2 (sv) * | 2006-12-05 | 2009-08-04 | Bengt-Sture Ershag | Anläggning för återvinning av kol och kolväteföreningar genom pyrolys |
| CN101835449A (zh) * | 2007-08-31 | 2010-09-15 | Dsmip资产有限公司 | 4-脒基苄胺用于美容和/或皮肤病学的用途 |
| CN101977626A (zh) * | 2008-01-21 | 2011-02-16 | 德莫迪斯公司 | 丝氨酸蛋白酶抑制剂在治疗皮肤病中的用途 |
| US10377818B2 (en) | 2015-01-30 | 2019-08-13 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating glioma |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290762A (en) * | 1986-12-24 | 1994-03-01 | John Lezdey | Treatment of inflammation |
| DE3829523A1 (de) * | 1988-08-31 | 1990-03-01 | Behringwerke Ag | Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression |
| US5304482A (en) | 1989-03-06 | 1994-04-19 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| AU637791B2 (en) | 1989-03-06 | 1993-06-10 | Board Of Regents, The University Of Texas System | Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
| US5550042A (en) | 1989-03-06 | 1996-08-27 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same |
| CA2021660A1 (en) * | 1989-07-26 | 1991-01-27 | Philippe Bey | Peptidase inhibitors |
| DE69030920T2 (de) | 1989-09-05 | 1998-02-19 | Biotechnology Australia Pty. Ltd., East Roseville, Neussuedwales | Verfahren zur herstellung von pai-2 |
| US5204807A (en) | 1989-10-04 | 1993-04-20 | Pitney Bowes Plc. | Postage meter housing arrangement having RF and electromagnetic induction shielding |
| JP2567536B2 (ja) | 1989-12-20 | 1996-12-25 | バイオテック オーストラリア プロプライアタリィ リミティド | Ｐａｉー２の変異体 |
| US5242801A (en) | 1990-08-06 | 1993-09-07 | University Of Iowa Research Foundation | Diagnosing malignant hyperthermia susceptibility by detection of abnormal proteolytic enzyme digestion fragments of the ryanodine receptor |
| JPH06279316A (ja) * | 1993-03-25 | 1994-10-04 | Shiseido Co Ltd | 皮膚外用剤 |
| US5403482A (en) | 1993-10-12 | 1995-04-04 | Gelman Sciences Inc. | Self-supporting, pleated, spirally wound filter and the corresponding process of making |
| GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
| US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| US5939525A (en) * | 1995-03-27 | 1999-08-17 | Viron Therapeutics, Inc. | Methods of treating inflammation and compositions therefor |
| KR20010042402A (ko) * | 1998-04-01 | 2001-05-25 | 로잘란드 앤 칼도르 | 피부 상처의 치료를 위한 프로테아제 억제제의 용도 |
-
1998
- 1998-08-05 AU AUPP5087A patent/AUPP508798A0/en not_active Abandoned
-
1999
- 1999-08-05 CN CN99811799A patent/CN1322138A/zh active Pending
- 1999-08-05 US US09/368,164 patent/US6288025B1/en not_active Expired - Fee Related
- 1999-08-05 IL IL14105699A patent/IL141056A0/xx unknown
- 1999-08-05 EP EP99938478A patent/EP1102599A4/de not_active Withdrawn
- 1999-08-05 JP JP2000563303A patent/JP2002522396A/ja active Pending
- 1999-08-05 KR KR1020017001554A patent/KR20010072278A/ko not_active Application Discontinuation
- 1999-08-05 WO PCT/IB1999/001483 patent/WO2000007620A1/en not_active Application Discontinuation
- 1999-08-05 CA CA002339485A patent/CA2339485A1/en not_active Abandoned
-
2001
- 2001-02-02 NO NO20010569A patent/NO20010569L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2339485A1 (en) | 2000-02-17 |
| EP1102599A4 (de) | 2004-03-17 |
| NO20010569D0 (no) | 2001-02-02 |
| CN1322138A (zh) | 2001-11-14 |
| EP1102599A1 (de) | 2001-05-30 |
| JP2002522396A (ja) | 2002-07-23 |
| IL141056A0 (en) | 2002-02-10 |
| US6288025B1 (en) | 2001-09-11 |
| AUPP508798A0 (en) | 1998-08-27 |
| KR20010072278A (ko) | 2001-07-31 |
| WO2000007620A1 (en) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE307111T1 (de) | Serinprotease-inhibitoren | |
| IL158559A0 (en) | Acne treatment | |
| ATE310087T1 (de) | Plasma-kallikrein inhibitoren vom kunitz-typ | |
| CY1110527T1 (el) | Διαρυλ ενωσεις ως αναστολεις πρωτεασης σερινης | |
| MXPA03009130A (es) | Compuestos de biarilo que funcionan como inhibidores de proteasa serina. | |
| ATE234117T1 (de) | Verwendung des sekretorischen leukozytaren protease inhibitors (slpi) als tryptase-inhibitor | |
| DK1272154T3 (da) | Præparat til forbedring af hudlipidbarrierefunktionen | |
| ATE439853T1 (de) | Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin | |
| WO1998022098A3 (en) | Cpp32 inhibitors for regulating apoptosis | |
| DE60026279D1 (de) | Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i | |
| EP1032393A4 (de) | Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease | |
| WO2002060869A3 (en) | Use of p38 inhibitors for the treatment of inflammation-enhanced cough | |
| BR9815469A (pt) | Inibidores de protease | |
| NO20010569L (no) | Proteaseinhibitorer for anvendelse ved behandling av psoriasis | |
| MX169931B (es) | Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas | |
| ATE131066T1 (de) | Mittel zur hemmung von hiv-proteasen. | |
| NO20004920L (no) | Anvendelse av proteaseinhibitorer for behandling av hudsår | |
| AR021241A1 (es) | Inhibidores de proteasas | |
| MY132033A (en) | New mandelic acid derivatives and their use as thrombin inhibitors | |
| TR200000954T2 (tr) | Mikrodolaşım hastalıklarının tedavisi ve önlenmesi için madde. | |
| SE9904059D0 (sv) | Serine protease and topical retinoid compositions | |
| EA200301130A1 (ru) | Применение ингибиторов протеазы вируса иммунодефицита человека (вич) для блокирования миграции клеток и/или инвазии, инфильтрации тканей и отека при лечении связанных с этим заболеваний | |
| DK0666841T3 (da) | Succinoylamino-hydroxyethylaminosulfaminsyrederivater til anvendelse som inhibitorer af retrovirale proteaser | |
| WO2003028621A3 (de) | Proteinaseinhibitoren zur therapie und diagnose von neurodegenerativen erkrankungen | |
| IS7162A (is) | Nýjar möndlusýruafleiður og notkun þeirra sem þrombínhemla |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |